Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by diyodton Dec 21, 2012 9:17pm
242 Views
Post# 20763948

RE: News...Good or Bad?

RE: News...Good or Bad?

Bit of a whopper today. Not sure what I think of it yet. We have to remember that we got a milestone payment for worlwide rights (4 mill if I recall) so if BNC has a plan to have Urocidin approved by some other regulator than FDA, (probably Health Can) then it makes sense to push ENDO to give it back and the price was royalties.

.

I think most agree the drug works and the problem is how to replace a toxic $1000 standard with a $30,000 non toxic one. I suspect doctors in jurisdictions like the US that have private healthcare ie HMO's have a tough time getting them to cough up 30x as much, hence the refractory trial. I think we just need it approved, wether it's head to head to BCG or some other way. My thinking has always been, why not go head to head with BCG, but Urocidin is given post TURBT (BCG can't be) which helps offset some of Urocidin price disadvantage. Short of that, our Phase3A might be good enough for approval, then we educate the doctors so they start prescribing.

.

Now we have two blockbuster products whose success depends on outsiders. That is the tragedy.

On January 10th we'll find out of the gag order's been lifted.

Merry Christmas

Bullboard Posts